SCHEMBL30784385

SCHEMBL30784385

Cc1cc(Br)c2nc(C3CCOCC3)[nH]c(=O)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMIGD3 P0DMS9 1/20 0.41
ADORA1 P30542 1/20 0.41
CDC7 O00311 3/20 0.40
PIM1 P11309 3/20 0.40
CSNK2B P67870 3/20 0.40
CSNK2A1 P68400 3/20 0.40
PARP14 Q460N5 3/20 0.40
PARP1 P09874 1/20 0.40
TYK2 P29597 1/20 0.38
DAO P14920 1/20 0.35
PRNP P04156 2/20 0.34
PPARG P37231 1/20 0.34
HTT P42858 1/20 0.34
NCOA2 Q15596 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
PDE9A O76083 3/20 0.34
PIK3CA P42336 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783587 0.85 CDC7 (0.40) TMIGD3ADORA1CDC7PIM1CSNK2B
SCHEMBL30784315 0.82 TMIGD3 (0.39) TMIGD3ADORA1CDC7PIM1CSNK2B
SCHEMBL30783861 0.75 KMT2A (0.48) TMIGD3CDC7PIM1PARP1HTT
SCHEMBL22600573 0.75 PARP14 (0.41) TMIGD3ADORA1CDC7PIM1CSNK2B
SCHEMBL30783662 0.74 PDE1B (0.41) PIK3CAPDE1C
SCHEMBL30783874 0.71 TMIGD3 (0.38) TMIGD3ADORA1CDC7PIM1CSNK2B
SCHEMBL25359756 0.71 PARP1 (0.49) PIM1PARP1PRNPPPARGHTT
SCHEMBL30494981 0.71 PARP1 (0.49) PIM1PARP1PRNPPPARGHTT
SCHEMBL30762450 0.71 PRNP (0.34) PRNPPPARGHTTNCOA2NPSR1
SCHEMBL30784410 0.70 PIK3CA (0.40) PRNPPPARGHTTNCOA2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed